Breaking News
POSITION PAPER | Strengthening the Resilience of EU Health Systems
THAL PALS PODCAST | New Episode on TIF’s NTDT Guidelines Out Now
Imatinib’s Impact on Reducing Painful Episodes in Sickle Cell Disease
WEBINAR | Official Launch of TIF’s Nutrition Guidelines in Thalassaemia and PKD
EXCITING ADVANCEMENTS IN BLOOD TRAΝSFUSION THERAPY | FDA Approves Hemanext ONE®
WEBINAR | Haemoglobin Disorders and EU Health Policies, 21 September 2023
CLINICAL NEWS | FDA Approves Luspatercept for First-line Treatment of Anemia in Lower-Risk MDS
TIF European Health Policy Webinar Series | 21 September 2023
TIF2023 | 16th International Conference on Thalassaemia & Haemoglobinopathies, November 3-5
PUBLICATIONS | Nutrition Guidelines in Thalassemia & PKD
English
Deutsch
Italiano
العربية
English
Ελληνικά
Français
Menu
Home
Who we are
TIF History
Vision & Mission
Pillars of Work
Board of Directors
Staff Members
TIF Members
Collaborations
Transparency
Awards & Honours
What we do
Education
Country Work
Projects
Global Thalassaemia Review
COVID-19 Pandemic & TIF
Surveys
Haemoglobin Disorders
Thalassaemia
Sickle Cell Disease
Clinical Trial Updates
Positions & Policies
Policy Framework
Position Papers
Official Statements
Publications
TIF Publications
Scientific Literature
Additional Resources
Media Centre
News
Newsletters
Events
Videos
Contact us
Search for
Home
/
EBMT23
EBMT23
EBMT23
April 19, 2023
ΕΒMΤ 49th Annual Meeting | 23-26 April 2023
Read More »
Back to top button
Close
Search for
